AL amyloidosis

A plasma cell disorder characterized by the aggregation and deposition of insoluble amyloid fibrils derived from misfolding of monoclonal immunoglobulin light chains usually produced by a plasma cell tumor. It usually presents as primary systemic amyloidosis (PSA) with multiple organ involvement and less frequently as primary localized amyloidosis (PLA) restricted to a single organ.

Syncope

Syncope refers to a generalized weakness of muscles with loss of postural tone, inability to stand upright, and loss of consciousness. Once the patient is in a horizontal position, blood flow to the brain is no longer hindered by gravitation and consciousness is regained. Unconsciousness usually lasts for seconds to minutes. Headache and drowsiness (which usually follow seizures) do not follow a syncopal attack. Syncope results from a sudden impairment of brain metabolism usually due to a reduction in cerebral blood flow.


Total: 4

                      


(per page)
PMID (PMCID)
27499835
(4961869)
OTHER
Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib.
Jaipaul N, Pi A, Zhang Z.
Hematol Rep. 2016;8(2):6417.
Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib.
27499835
(4961869)
OTHER
Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib.
Jaipaul N, Pi A, Zhang Z.
Hematol Rep. 2016;8(2):6417.
We report a case of a 48-year-old man with AL amyloidosis and increased frequency of syncope and cardiac arrest after starting bortezomib.
27499835
(4961869)
OTHER
Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib.
Jaipaul N, Pi A, Zhang Z.
Hematol Rep. 2016;8(2):6417.
The biologic and clinical plausibility of a heightened risk for cardiac arrest in patients with cardiac AL amyloidosis and history of syncope being treated with bortezomib is a possibility that is not well documented in the medical literature and warrants further investigation.
9049685
MALE Middle Aged
Primary amyloidosis and syncope.
Rodriguez Reguero J, Iglesias Cubero G, Rubin J.
Int J Cardiol. 1997;58(2):185-7.
Primary amyloidosis and syncope.